191 – 200 of 481
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Anthropometric measures and bladder cancer risk: A prospective study in the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Coffee and tea consumption, genotype- based CYP1A2 and NAT2 activity and colorectal cancer risk- Results from the EPIC cohort study
(
- Contribution to journal › Article
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article
-
Mark
Inherited variation in the PARP1 gene and survival from melanoma
(
- Contribution to journal › Article
-
Mark
Special section editorial.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort
(
- Contribution to journal › Article
-
Mark
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Prediagnostic telomere length and risk of B-cell lymphoma-Results from the EPIC cohort study
(
- Contribution to journal › Article
-
Mark
The population impact of familial cancer, a major cause of cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome
(
- Contribution to journal › Article